Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bristol Myers (BMY – Research Report) and Capital Senior Living (CSU – Research Report).
Bristol Myers (BMY)
Barclays analyst Carter Gould maintained a Hold rating on Bristol Myers on July 28 and set a price target of $71.00. The company’s shares closed last Thursday at $68.15, close to its 52-week high of $68.99.
According to TipRanks.com, Gould is a 3-star analyst with an average return of
Bristol Myers has an analyst consensus of Moderate Buy, with a price target consensus of $73.50, representing a 6.5% upside. In a report released yesterday, Morgan Stanley also maintained a Hold rating on the stock with a $71.00 price target.
See today’s analyst top recommended stocks >>
Capital Senior Living (CSU)
In a report issued on July 28, Steven Valiquette from Barclays maintained a Sell rating on Capital Senior Living, with a price target of $23.00. The company’s shares closed last Thursday at $30.75.
According to TipRanks.com, Valiquette is a 3-star analyst with an average return of
Currently, the analyst consensus on Capital Senior Living is a Moderate Sell with an average price target of $23.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BMY: